Three CRY2 SNPs, rs11038689, rs7123390 and rs1401417, were found to be associated with risk of developing non-Hodgkin lymphoma (NHL) in a predominantly Caucasian cohort consisting only of female patients. This evidence concerns the gene CRY2 and non-Hodgkin lymphoma.